Memory Loss Is Not Aging, It's an Infection - Dr. Richard Horowitz | TUH #302

Audio Brief

Show transcript
In this conversation, human biologist Gary Brecka and board-certified internist Dr. Richard Horowitz explore how hidden chronic infections, environmental toxins, and gut dysfunction drive systemic inflammation, autoimmune conditions, and neurodegenerative diseases like Alzheimer’s. There are four key takeaways from this discussion. First, chronic illnesses are driven by an ocean of inflammation fed by six primary sources, requiring a 16-point diagnostic model rather than mere symptom management. Second, elusive tick-borne infections like Lyme disease frequently evade standard blood tests, requiring clinical diagnosis based on hallmark symptoms like migratory pain. Third, targeting bacterial biofilms with a short-term dapsone combination therapy can induce long-term remission in chronic Lyme patients and even reverse Alzheimer’s biomarkers. Finally, cellular defense requires shutting down four core inflammatory pathways while properly testing for intracellular mineral deficiencies and mycotoxins. Expanding on the first takeaway, chronic disease accounts for 86 percent of US healthcare costs, and 42 percent of people over age 55 are projected to develop dementia. Dr. Horowitz explains that these conditions are fueled by six rivers of inflammation: polymicrobial infections, environmental toxins, gut microbiome dysfunction, leaky gut with mast cell activation, intracellular vitamin and mineral deficiencies, and sleep disorders. Through molecular mimicry and systemic damage, these factors trigger ten downstream effects. These include postural orthostatic tachycardia syndrome, hormone depletion, and false-positive autoimmune profiles mimicking lupus, rheumatoid arthritis, multiple sclerosis, and even ALS. Regarding the second takeaway, one in seven people globally has been exposed to Lyme disease, yet standard CDC two-tiered testing fails because it screens for only a single laboratory strain. Consequently, Lyme must be diagnosed clinically and confirmed via multi-strain testing like IGeneX Labs. The definitive clinical hallmark present in 95 percent of Lyme patients is migratory joint and muscle pain, alongside migratory neuropathy like shifting numbness or burning. Clinicians must also look for co-infections present in up to 90 percent of chronic cases, such as Babesia, which causes drenching night sweats, and Bartonella, which produces distinct purple perpendicular stretch marks. Turning to the third takeaway, researchers have proven that Lyme is a biofilm persister bacteria, meaning pathogens hide beneath protective layers to evade the immune system and standard single-antibiotic treatments. By combining antibiotics that target different cellular compartments with dapsone, a leprosy drug that penetrates the central nervous system and eradicates persister forms, Horowitz achieved long-term remission in over half of his chronic Lyme patients using a nine-week oral protocol. Remarkably, half of his chronic Lyme patients test positive for Alzheimer's blood biomarkers without carrying the genetic risk allele. In a published case study, his nine-week dapsone protocol lowered a patient's p-tau217, the most specific Alzheimer’s biomarker, by 63 percent back to normal, far outperforming standard anti-amyloid drugs. Finally, because 90 percent of Horowitz’s patients test positive for mold mycotoxins and 20 percent have mineral deficiencies, proper testing and cellular protection are vital. Since 99 percent of minerals reside inside cells, doctors must order red blood cell mineral levels for magnesium, zinc, and copper rather than standard serum panels, and provoke urine mold tests using oral glutathione and sauna sweating. To protect the brain and body, Horowitz targets four cellular inflammatory pathways: blocking NF-kappaB using glutathione, NAC, and alpha-lipoic acid; stimulating the Nrf2 detox pathway with curcumin, resveratrol, and broccoli seed extract; inhibiting NLRP3 inflammasomes using low-dose naltrexone and melatonin; and blocking inflammatory prostaglandins with omega-3 fatty acids. Ultimately, resolving complex chronic and neurodegenerative illnesses requires abandoning superficial disease labels to systematically unlayer and treat the root infectious, toxic, and inflammatory causes.

Episode Overview

  • Host Gary Brecka (a 55-year-old human biologist and host of The Ultimate Human Podcast) and guest Dr. Richard Horowitz (a 70-year-old board-certified internist trained at the Free University of Brussels in French for 7 years with a Mount Sinai residency in HIV medicine, who has treated over 13,000 patients over 41 years) explore how hidden chronic infections, environmental toxins, and gut dysfunction drive chronic inflammation, autoimmune conditions, and neurodegenerative diseases like Alzheimer’s and dementia.
  • Framed around Brecka’s personal mission to reverse his mother’s rapid cognitive and short-term memory decline, the discussion challenges standard symptom-management medicine by introducing Dr. Horowitz’s 16-point MSIDS (Multiple Systemic Infectious Disease Syndrome) model.
  • The narrative progresses from diagnosing elusive tick-borne infections—such as Lyme disease, Bartonella, and Babesia—to breaking down biofilm persister bacteria using novel combination therapies like the oral dapsone protocol.
  • Listeners learn how "six rivers of inflammation" trigger ten downstream systemic effects (including POTS, hormone depletion, and autoimmune mimicry), and how targeting four key cellular inflammatory pathways can protect the brain and body.
  • Disclosures: Gary Brecka discloses ties to his subscription platform The Ultimate Human VIP Community (theultimatehuman.com/vip, costing less than $100 a month), sponsor Baja Gold Mineral Sea Salt, and The Ultimate Snooze (theultimatesnooze.com, an organic mattress company he backs, offering 10% off with code ULTIMATE). Dr. Horowitz promotes his book Ending Chronic Illness (endingchronicillness.com), his free Medical Detective Substack, and his website cangetbetter.com, while mentioning clinical preferences for specific labs and supplement brands without disclosed financial ties.

Key Concepts

  • The Chronic Disease and Dementia Crisis: Chronic diseases account for 86% of US healthcare costs, 70% of deaths, and 18% of US GDP, with the US spending $5 trillion annually on healthcare despite estimates that 85% of chronic disease is preventable. According to the NIH, 42% of people aged 55 or older are expected to develop dementia, and while the NIH spends $2.4 billion a year on Alzheimer's research, standard treatments fall short. Furthermore, 1 in 5 Americans suffers from depression and anxiety, 750,000 people die by suicide worldwide annually, and the US loses more military servicemen and law enforcement officers to suicide than in the line of duty.
  • The 16-Point MSIDS Model ("Six Rivers of Inflammation"): Dr. Horowitz Conceptualizes chronic illness as an "ocean of inflammation" fed by six primary rivers: (1) Infections, (2) Environmental Toxins, (3) Gut Microbiome Dysfunction, (4) Leaky Gut and Mast Cell Activation, (5) Intracellular Vitamin and Mineral Deficiencies, and (6) Sleep Disorders/Insomnia (noting that 10% of young, thin women have obstructive sleep apnea, and insomnia elevates Interleukin-6).
  • Polymicrobial Infections and Immune Exhaustion: According to BMJ Global Health, 14.5% of the world’s population (1 in 7 people) has been exposed to Lyme disease (Borrelia burgdorferi). However, chronic illness is rarely caused by a single pathogen; it involves intracellular bacteria (Chlamydia pneumoniae, Mycoplasma pneumoniae, Mycoplasma fermentans, various Borrelia species, and 18 species of Bartonella, which appears in 80% to 90% of Horowitz's chronically ill patients), viruses (EBV, CMV, HHV-6, HSV-1, HSV-2, parvovirus), fungi (Candida, and fungal infections found in Alzheimer's brains), and parasites (Babesia microti, Babesia duncani, Babesia odocoilei found in 60%–80% of his Lyme patients, and Toxoplasma, which infects one-third of the world's population and is linked to neurocognitive decline). Lyme causes chronic variable immune deficiency in 20% of his patients and subclass deficiencies in 85%. Mechanistically, Lyme and Bartonella exhaust antibody-producing B-cells, Long COVID exhausts T-cells, and mold gliotoxins poison the immune system.
  • Flaws in Standard Lyme Testing vs. Clinical Diagnosis: Because 90% of medical diagnoses rely on clinical history, Lyme is a clinical diagnosis. The standard CDC two-tiered test (ELISA followed by Western blot) is unreliable because it is based on a single laboratory strain (B31) rather than environmental strains; Horowitz prefers IGeneX Labs, which tests 9 strains. Migratory joint/muscle pain appears in 95% of Lyme patients, and migratory neuropathy (tingling, numbness, burning, stabbing, vibration) appears in 90% to 95%. Only 7 diseases in medicine cause migratory pain (including lupus, gonococcal arthritis, inflammatory bowel disease, Reiter's syndrome, and Lyme), and Lyme is the only disease that causes migratory neuropathy. Symptoms in women frequently worsen around menstruation when estrogen drops. Combining migratory pain and good/bad days with just one Lyme-specific Western blot band—23 (OspC), 31 (OspA), 34 (OspB), 39, or 83/93—confirms Lyme exposure ("Lyme Bingo").
  • Biofilm Persister Bacteria and Dapsone Therapy: Around 2015, researchers from Johns Hopkins, University of New Haven (Eva Sapi’s group), Northeastern University (Kim Lewis), and Stanford proved that Lyme is a "biofilm persister bacteria" similar to tuberculosis and leprosy (which is cured using rifampin and dapsone for 1 year). Different antibiotics must target different compartments: Amoxicillin and IV Rocephin hit cell wall forms; doxycycline, Zithromax, rifampin, and quinolones hit intracellular compartments; Flagyl (metronidazole) and Plaquenil hit cystic/cell-wall-deficient L-forms; and dapsone penetrates the central nervous system, modulates autoimmunity, reduces inflammation, and eradicates biofilm persister forms.
  • Clinical Remission via the Dapsone Protocol: Horowitz published his first dapsone combination study in 2016 and has published 10 studies on dapsone (out of 11 total in the literature, including an animal model study by Tufts University and culture models combining dapsone with doxycycline/minocycline, rifampin, and azithromycin). He discovered the optimal dosage when a patient sick for 7 years accidentally took double the prescribed dose (100 mg twice daily) for 1 month, experienced a massive Herxheimer reaction, stopped all medications, and went into complete remission. Subsequently, Horowitz’s wife—who suffered from chronic Lyme for 25 years and relapsed after taking 50 mg of dapsone for a year and 100 mg for 6 months—took the double dose (100 mg twice daily) for 1 month and has been in full remission for 8 years. His 9-week oral dapsone protocol puts at least 50% of chronic Lyme patients into long-term remission (if active Babesia, Bartonella, and mold are absent), while Bartonella requires four 2-week pulses (with 6 days of dapsone per pulse). Horowitz acknowledges he does not yet have a randomized, multicenter, placebo-controlled trial because the NIH rejected his grant application due to politics.
  • Reversing Alzheimer’s Biomarkers: Horowitz published the first study in the Journal of Alzheimer's Disease Reports demonstrating that all 16 MSIDS factors apply to Alzheimer’s. Notably, 50% of his chronic Lyme patients tested positive for Alzheimer's blood biomarkers despite none carrying the genetic APOE 4/4 risk allele. In his published case study, a patient with chronic Lyme for 15 years (with no antibiotic use during that time) completed the 9-week oral dapsone protocol; 3 months later, her p-tau217 (the most sensitive and specific Alzheimer’s biomarker) lowered by 63% in 9 weeks, returning to normal. By comparison, a Cochrane review noted anti-amyloid antibodies (lecanemab, donanemab) make little clinical difference, lowering biomarkers by 23% over 6 years. Horowitz hedges that anti-amyloid drugs might work better if doctors first treated underlying infections and mold, and remarks at the close of the episode that he could "maybe—maybe—find a cure and an answer for certain cases of Alzheimer's." Other infectious links to Alzheimer's include Porphyromonas gingivalis, a bacterium hiding under dental plaque biofilms.
  • Environmental Toxins and Systemic Damage: CDC data shows 150 to 200 toxins regularly appear in human blood and urine (Horowitz believes it is thousands), and 90% of his patients test positive for multiple mold mycotoxins (ochratoxins, trichothecenes, gliotoxins, aflatoxins). Endocrine-disrupting chemicals have driven a 66% decline in male sperm counts (dropping another 1% per year, according to Brecka). Furthermore, one-third of the world's population has silent non-alcoholic fatty liver disease (NAFLD) driven by PFAS toxins, leading to insulin resistance, metabolic syndrome, cirrhosis, and liver cancer.
  • Ten Downstream Effects & Autoimmune Mimicry: The six rivers of inflammation cause ten downstream effects: mitochondrial dysfunction (worsened by statins lowering CoQ10), hormonal dysfunction, POTS/dysautonomia, immune dysfunction, autoimmunity, liver disease, pain syndromes, mood disorders, neuropsychiatric/cognitive issues, and deconditioning. Through molecular mimicry, Lyme and toxins cause positive ANA (mimicking lupus), positive rheumatoid factor with negative CCP (mimicking rheumatoid arthritis, which is also triggered by the mouth bacterium Aggregatibacter, gut imbalances in Prevotella, Firmicutes, and Bifidobacterium, and low short-chain fatty acids), and thyroid antibodies (mimicking Hashimoto's). Multiple Sclerosis is linked to EBV variants, Chlamydia pneumoniae, Lyme, Bartonella, and mold (illustrated by MS appearing in the Faroe Islands only after British troops invaded). Additionally, 10% of ALS patients in Horowitz's practice actually had reversible Lyme-induced demyelination mimicking ALS, though he caveats that most ALS cases are unfortunately genetic with superoxide dismutase problems.
  • POTS, Bartonella, and Extraordinary Clinical Reversals: The four primary causes of POTS (Postural Orthostatic Tachycardia Syndrome, often linked with Ehlers-Danlos syndrome/hypermobility) are Lyme, Bartonella, Long COVID, and mold. Horowitz shares the case of a 15-year-old girl from Tennessee confined to a wheelchair on 480 mg of morphine sulfate daily with pseudo-seizures, a heart rate jumping to 140 bpm upon standing (POTS), drenching sweats (Babesia), and purple perpendicular stretch marks (Bartonella striae). Treated with doxycycline, rifampin, Malarone, salt, fluids, and licorice, she walked out of her wheelchair pain-free and off all morphine 1 month later. Another patient who could not speak for 5 years (dysarthria/aphasia) regained her speech after Bartonella treatment.
  • Long COVID and Epstein-Barr Virus (EBV) Mechanisms: COVID disrupts gut Bifidobacterium, lowering serotonin (explaining why fluvoxamine helps Long COVID), while elevated VEGF on a Long Hauler panel (Patterson's Lab) is frequently driven by underlying Bartonella rather than just spike proteins. For chronic EBV, a literature dive led Horowitz to combine spironolactone (a PCOS drug), dipyridamole/Persantine (a stroke drug), and an antiviral like famciclovir to shut down EBV replication at every stage—though he explicitly hedges that he needs a randomized multicenter trial because "association does not always equal causation."
  • The Four Core Cellular Inflammatory Pathways: To protect cells—and because every member of his immediate family died of cancer—Horowitz takes two gallon-sized Ziploc bags of supplements daily (speculating this regimen may have protected him and his wife when their house had black mold). His protocol targets four pathways:
  • Blocking NF-kappaB (the nuclear switch for TNF-alpha, IL-1, and IL-6) using NAC, Alpha-Lipoic Acid (ALA), and Glutathione (lung tissue has 140 times more glutathione than anywhere else, and viruses like COVID, influenza, dengue, and HIV must lower glutathione to replicate).
  • Stimulating Nrf2 (which shuts down the p53 cancer gene, opens detox pathways, and creates cytoprotective proteins) using curcumin, green tea extract (EGCG), resveratrol (which also targets sirtuin longevity genes), and sulforaphane glucosinolate (broccoli seed extract; 100 to 300 mg started reversing autistic symptoms in children by inhibiting the hyperstimulated mTOR pathway common to both autism and Alzheimer's).
  • Blocking NLRP3 Inflammasomes (implicated in cancer and Alzheimer's) using the above antioxidants plus Low-Dose Naltrexone (LDN) and low-dose melatonin.
  • Blocking Inflammatory Prostaglandins using omega-3 fatty acids and intracellular minerals.

Quotes

  • At 0:00:00 - "42% of people 55 years or older expected to become demented. And yet they spend $2.4 billion a year at the NIH, and no one has come up with a solution for it." - Dr. Horowitz framing the scale of the impending dementia crisis and the failure of conventional research funding.
  • At 0:00:10 - "When you realize that we spend $5 trillion a year on healthcare, we estimate that 85% of all chronic disease is preventable, we have to start looking at things like our chemical supply, our food supply, our water, our air, as micro-toxic environments that accumulate over time." - Gary Brecka highlighting the economic burden of preventable disease and the role of cumulative environmental toxicity.
  • At 0:00:28 - "All chronic disease is driven by chronic inflammation. But where's the inflammation coming from? Bacteria, viruses, parasites, fungi, microbiome issues in the gut, vitamin, mineral deficiencies, sleep disorders." - Dr. Horowitz summarizing the foundational causes of chronic inflammation in his MSIDS model.
  • At 0:00:40 - "We are waking up to infectious disease and toxicity as a root cause of some of the most prevalent chronic conditions that plague society and mankind." - Gary Brecka introducing the paradigm shift away from symptom management toward root-cause medicine.
  • At 0:06:36 - "And I just reversed p-tau217, the most sensitive and specific Alzheimer's biomarker, for the first time ever in the world, using a 9-week oral antibiotic protocol, very short-term." - Dr. Horowitz sharing his published case study breakthrough linking chronic Lyme treatment to the reversal of an Alzheimer's biomarker.
  • At 0:10:09 - "90% of my patients are now showing positive for multiple mycotoxins." - Dr. Horowitz emphasizing the pervasive role of mold toxicity in chronically ill populations.
  • At 0:16:07 - "There is one specific factor people need to know about Lyme that shows up in 95%, which is migratory pain. If you have migratory muscle pain, migratory joint pain, where one day your knee hurts and two days later your shoulder hurts and three days later your ankle hurts, that is a hallmark symptom of Lyme, as well as migratory neuropathy." - Dr. Horowitz explaining the primary clinical differentiator for diagnosing Lyme disease.
  • At 0:18:13 - "Well, the two-tiered test by the CDC of an ELISA followed by a Western blot was done on one strain of Lyme disease, which is the B31 laboratory strain. That is not the strain that is in the environment that is making most people sick." - Dr. Horowitz explaining why standard blood tests miss the majority of clinical Lyme cases.
  • At 0:26:23 - "My wife, who had been sick for 25 years with chronic Lyme, is now 8 years in full remission since she did dapsone combination therapy." - Dr. Horowitz recounting the personal validation of his high-dose dapsone persister drug protocol.
  • At 0:28:46 - "Your immune system cannot recognize these bugs when it's under the biofilms, that's exactly right. And in fact, why do you go to the dentist and take the plaque off your teeth? It's because Porphyromonas gingivalis, which causes—a cause of Alzheimer's—is under the biofilms on your teeth." - Dr. Horowitz using dental plaque as an analogy to explain how bacterial biofilms shield pathogens from the immune system and drive neurodegeneration.
  • At 0:33:12 - "It's no longer enough to name a disease and throw drugs at it. You must unlayer every illness into these 16 points." - Dr. Horowitz critiquing conventional diagnostic labels in favor of his 16-point checklist approach.
  • At 0:41:58 - "Or they check their minerals, but they don't know that 99% of their minerals are inside the red blood cells. So you need magnesium for 300 detoxification enzymes in your body." - Dr. Horowitz pointing out why standard serum mineral tests fail to detect critical intracellular deficiencies.
  • At 0:49:46 - "10% of our ALS patients who came in did not have true ALS. They had Lyme-induced ALS; we were able to stop the process and reverse it." - Dr. Horowitz illustrating how tick-borne infections can mimic fatal neurodegenerative diseases.
  • At 1:04:54 - "Do you know that they gave sulforaphane to autistic kids between 100 to 300 milligrams, and it started reversing autistic syndrome? Because it hits a biochemical pathway called the mTOR pathway, right, the mechanistic target of rapamycin, which you need for longevity." - Dr. Horowitz connecting Nrf2 activation via broccoli seed extract to mTOR inhibition in autism and Alzheimer's.
  • At 1:16:17 - "The anti-amyloid drugs lower these biomarkers by 23% in 6 years. I lowered it by 63% in 9 weeks because the amyloid was being driven by Lyme Borrelia burgdorferi." - Dr. Horowitz contrasting the efficacy of conventional anti-amyloid pharmaceuticals against targeted antimicrobial therapy.
  • At 1:20:36 - "Medicine needs to know: you can't just name the disease and throw drugs at it. You've got to unlayer to the 16 root causes." - Dr. Horowitz reiterating his core philosophy for resolving complex chronic and neuropsychiatric illnesses.

Takeaways

  • Screen for Lyme and Co-Infections Clinically: Take the free, validated 38-question Horowitz MSIDS Questionnaire (HMQ) at cangetbetter.com (a score over 63 indicates a very high probability of Lyme). Watch for migratory joint/muscle pain, migratory neuropathy, symptoms that flare around menstruation, unexplained fevers/night sweats/air hunger (classic signs of Babesia), and purple or whitish stretch marks running perpendicular to the skin plane in non-overweight individuals (a clinical sign of Bartonella). Request multi-strain testing via IGeneX Labs rather than relying solely on the CDC two-tiered test.
  • Test Intracellular (RBC) Minerals and Occult B12: Do not rely on standard serum mineral panels, as 99% of minerals reside inside cells and 20% of chronically ill patients are mineral deficient. Ask your doctor to order Red Blood Cell (RBC) levels for magnesium (needed for 300 detox enzymes), zinc (needed for phase 1 liver detox of aldehydes), and copper (needed for superoxide dismutase) through Quest or Labcorp using ICD-10 code R79.9, and check methylmalonic acid to catch hidden B12 deficiencies.
  • Evaluate Mold Mycotoxins and Heavy Metals Properly: To test for mold toxins via RealTime Laboratories, provoke toxin release before collecting urine by taking 2,000 mg of oral liposomal glutathione, drinking 8 oz of purified water every 15 minutes, and sweating in a sauna for 15 to 20 minutes. To assess heavy metals (mercury, lead, arsenic, cadmium, aluminum), use a 6-hour urine DMSA or EDTA challenge test through Doctor's Data (~$60).
  • Order the 3-Stage Inflammatory and Alzheimer’s Blood Panels: Assess systemic inflammation using Stage 1 markers (CRP, ESR, TGF-beta-1, C4a, MMP-9), Stage 2 oxidative stress markers via Precision Point or Doctor's Data (lipid peroxides, 8-OHdG for DNA damage, protein carbonyls, TBARS), and Stage 3 cytokines/chemokines (CXCL3, CXCL4, interferon-gamma via Patterson's Lab) alongside Quest Diagnostics' 5 Alzheimer’s blood biomarkers: Amyloid-beta 42/40 ratio, p-tau181, p-tau217, Neurofilament light chain (NfL), and GFAP (essential for predicting 10-year dementia risk in APOE 4/4 carriers).
  • Implement the 4-Pathway Anti-Inflammatory & Acute Viral Supplement Protocol: Support cellular defense daily with NAC, Alpha-Lipoic Acid (note: 1,200 mg can cause blood sugar swings in hypoglycemics), liposomal glutathione, curcumin, sulforaphane (broccoli seed extract), EGCG (green tea extract), resveratrol, Low-Dose Naltrexone (LDN, 4.5 mg daily in the morning via a compounding pharmacy like Infuserve America), 1 mg melatonin at night, mercury-free omega-3s (such as Ortho Omega or wild organic salmon), and minerals (such as Xymogen MinRex plus magnesium malate, glycinate, or L-threonate). During an acute COVID or viral infection, Horowitz takes 2,000 mg of glutathione 3 times daily (6,000 mg max dose) alongside NAC and ALA.
  • Protect and Rebuild the Gut Microbiome and Mitochondria: When taking intensive antibiotic protocols (like the 9-week dapsone regimen), prevent C. diff and yeast overgrowth by taking 4 probiotics twice a day (totaling 500 trillion bacteria, such as Ortho Biotic) alongside nystatin (or treat Candida with fluconazole or itraconazole). For daily gut maintenance, combine probiotics with a prebiotic fiber (like Ortho Molecular MGP Fiber), a postbiotic (pDC Activate), and a low-histamine diet if dealing with mast cell activation or food allergies. Support mitochondria daily with ATP 360 (Researched Nutritionals), CoQ10, acetyl-L-carnitine, urolithin A probiotics, and MitoPrime (ergothioneine from Xymogen).
  • Restore Hormones Without Dependency: If a young man presents with low testosterone (often driven by Lyme disease), avoid exogenous testosterone injections that shrink the testicles; instead, work with a physician to address root infections while using clomiphene (to stimulate brain LH) and Arimidex/anastrozole (to block estrogen aromatization), which can raise testosterone from 100 to 600. Additionally, evaluate adrenal function using a DHEA/cortisol salivary test through Doctor's Data (~$100), as 99% of Horowitz's patients show low adrenal function.
  • Rewire the Nervous System After Trauma: Recognize that physical treatments for infections and toxins will fail if unaddressed childhood physical, emotional, or sexual abuse/PTSD keeps the nervous system locked in fight-or-flight. Pair medical protocols with EMDR, CBT, vagal retraining, or limbic system retraining programs (such as the Annie Hopper Dynamic Neural Retraining System, Gupta Amygdala & Insula Retraining, or Primal Trust), and practice Tibetan meditation for 5 minutes, 3 times a day to lower cortisol/epinephrine and lengthen telomeres.
  • Reduce Daily Environmental and Oral Biofilm Loads: Because dental plaque biofilms harbor Porphyromonas gingivalis (linked to Alzheimer's) and Aggregatibacter (linked to rheumatoid arthritis), maintain rigorous dental hygiene and regular cleanings. Minimize exposure to PFAS and endocrine-disrupting chemicals by filtering water, eating organic food, and upgrading sleep environments to organic materials to lower your cumulative toxic burden.